Navigation Links
EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
Date:2/7/2008

Application to be reviewed under European Accelerated Assessment Procedure

BOULDER, Colo., Feb. 7 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today announced that the European Medicines Agency (EMEA) has accepted for review the Company's Marketing Authorization Application (MAA) for Vidaza(R) (azacitidine for injection) in patients with higher-risk myelodysplastic syndromes (MDS) and announced its intent to review the application under the Accelerated Assessment Procedure. Pharmion submitted the Vidaza MAA to the EMEA earlier this month.

The Accelerated Assessment Procedure is granted for medicinal products that are expected to be of major public health interest, particularly from the point of view of therapeutic innovation. Accelerated Assessment reduces the time limit for the Committee for Medicinal Products for Human Use (CHMP) to give an opinion from 210 days to 150 days. At any time during the marketing authorization application evaluation, the CHMP may decide to continue the assessment under standard centralized procedure timelines.

The application is based upon clinical data which include the results from the Company's Phase 3 multi-center, international, randomized study of Vidaza(R) (azacitidine for injection) in the treatment of patients with higher-risk MDS. The primary objective of this Phase 3 trial was to demonstrate superiority in overall survival of Vidaza versus conventional care regimens, and these data were presented at the American Society of Hematology annual meeting in December 2007.

Vidaza has been designated as an Orphan Medicinal Product in the EU for the treatment of MDS, which, if approved, entitles the drug to ten years of market exclusivity for the approved indication
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. FDA Accepts Ranexa(R) sNDA and NDA for Filing
2. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
3. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
4. FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
5. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
6. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
11. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... SAN BRUNO, Calif. , Nov. 18, 2014 ... is a platinum sponsor of the 10th Annual World Stem ... and regenerative medicine stakeholders. The 2014 World Stem Cell Summit ... San Antonio, Texas . ... the discovery and development of lifesaving cures and therapies, convening ...
(Date:11/18/2014)... November 17, 2014 pH measurement and ... across the pharmaceutical, chemical, and food and beverage industries. ... important, and how do pH sensors work? METTLER TOLEDO ... those in process industries with these questions and more. ... measurement in the process industries. The actual sensor, the ...
(Date:11/18/2014)... 2014 American Process Inc. (Atlanta, ... a partnership with researchers at Georgia Institute of ... and the USDA’s Forest Products Laboratory to develop ... Nanocellulose is a rapidly emerging high performance nanomaterial ... is to replace heavy steel structures within cars, ...
(Date:11/18/2014)... 18, 2014 Array Architects is proud ... expertise to the nation's hospitals and health systems. It ... those dedicating their careers to the advancement of both ... in her respective field, Laura Silvoy has been chosen ... 2014 Winter Simulation Conference. , Laura will present ...
Breaking Biology Technology:Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3pH Guide from METTLER TOLEDO Explains Measurement, Theory and Practice of pH Applications 2American Process Inc. Announces Partnership to Develop Ultra-Strong, Lightweight Automotive Components Using Nanotechnology from Nature 2American Process Inc. Announces Partnership to Develop Ultra-Strong, Lightweight Automotive Components Using Nanotechnology from Nature 3Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2
... HAIKOU CITY, China , May ... ("China Pharma" or the "Company"), a leading,fully-integrated specialty pharmaceuticals company in ... 31, 2010 . , , First Quarter Highlights, ... in the first, quarter of fiscal ...
... vaccines and diagnostics that would help countless people worldwide ... of collaborations between biotech firms in developing countries, according ... in the UK journal Nature Biotechnology . ... at Canada,s McLaughlin-Rotman Centre for Global Health, interviewed over ...
... using ultracentrifugation (UCF) to create highly purified samples of ... Professor Junichiro Kono and graduate students Erik Haroz and ... toward the dream of an efficient nationwide electrical grid ... other, led by Rice Professor Bruce Weisman and graduate ...
Cached Biology Technology:China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 2China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 3China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 4China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 5China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 6China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 7China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 8China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 9China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 10China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 11Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 2Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 3Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 4Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 5Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 6Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms 7Nano parfait a treat for scientists 2Nano parfait a treat for scientists 3
(Date:11/11/2014)... 2014  Forensicon, Inc., a Chicago ... announce the promotion of Yaniv Schiff from ... In Schiff,s new role as Director, he will lead ... forensics examiners and provide leadership within the company,s digital ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon in ...
(Date:11/7/2014)... BURBANK, Calif. , Nov. 7, 2014  In conjunction ... Burbank Police Departments, The Community Foundation of the ... BURBANK DNA JUSTICE PROJECT," a $250,000 initiative to ... successful initial phase. In its first six months of existence, ... desperately needed evidence support for local law enforcement. ...
(Date:11/6/2014)... cancer deaths occur because of metastasis, yet progress ... been slow. , "It,s been particularly challenging to ... Gujral, research fellow in systems biology at Harvard ... detected until after they,ve already metastasized." , Gujral ... that should help researchers better understand how metastasis ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Migration negation 2Migration negation 3
... the Arctic is boosted by global warming, it,s not enough ... permafrost beneath the surface, University of Florida researchers have found ... thawing of permafrost in a warming world. Twice as ... the atmosphere today, and what happens to it as it ...
... the first time in mammalian brain cells, researchers at ... in building the circuitry that relays signals through the ... aging process in the brain, the researchers say. Additionally, ... discovery paves the way for faster progress toward identifying ...
... back on a shark" is the take home message from ... Erich Ritter of the Shark Research Institute and Raid Amin ... that sharks can comprehend body orientation and therefore know whether ... to approach and possibly attack their prey from the blind ...
Cached Biology News:UF researchers' experiment is first to simulate warming of Arctic permafrost 2UF researchers' experiment is first to simulate warming of Arctic permafrost 3Gene found to be crucial for formation of certain brain circuitry 2Sharks prefer to sneak up from behind, study shows 2
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
Formulation: 10mM PBS/500 mM NaCl, 0.09% NaN3, pH 7.2...
Rad51B...
Goat polyclonal to Dysadherin ( Abpromise for all tested applications). entrezGeneID: 53827...
Biology Products: